US$ 29.31
2.5 mg tirzepatide to units in TrimRX How to Inject Tirzepatide
Description
Notably, the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial, the first dedicated kidney outcome trial evaluating canagliflozin in people with type 2 diabetes mellitus and CKD, demonstrated a substantial reduction in the risk of kidney events [46]

Cardio-protection , the prevention of events as opposed to the loss of pounds, has a real-world signal in tirzepatide

doi: 10.1007/s12022-022-09708-2

AbbVie press release

If your protocol frequently requires fractional units, investing in half-unit syringes eliminates guesswork
